Drug Profile
Valproic acid oral - Banner Life Sciences
Alternative Names: Stavzor; Stavzor ER; Valproic acid delayed-release capsules (Stavzor); Valproic acid extended-release capsules (Stavzor ER)Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Banner Pharmacaps
- Developer Banner Life Sciences; Banner Pharmacaps
- Class Antiepileptic drugs; Antimigraines; Antithrombotics; Nootropics; Pentanoic acids; Small molecules; Vascular disorder therapies
- Mechanism of Action 4-aminobutyrate transaminase inhibitors; Glutamate decarboxylase stimulants; Neurotransmitter modulators; Sodium channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Bipolar disorders; Epilepsy; Migraine
Most Recent Events
- 01 Dec 2016 Banner Pharmacaps is now called Banner Life Sciences
- 14 Dec 2012 Banner Pharmacaps has been acquired by Patheon
- 22 Dec 2010 No development reported - Preclinical for Migraine prophylaxis in USA (PO, extended-release capsules)